Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Mastitis Chronic

Tundra lists 3 Mastitis Chronic clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT06667609

Validity and Reliability of the Mastitis Symptom Severity Assessment Methods (M-Score and BISSI) in Non-Lactational Mastitis

The purpose of this study is to evaluate the validity and reliability of the Mastitis-score (M-score) and the Breast Inflammatory Symptom Severity Index (BISSI) as measures for assessing symptom severity in non-lactational granulomatous lobular/periductal mastitis (NL-GLM/PDM). This research aims to provide a valid and reliable tool for evaluating both symptom severity and treatment efficacy in NL-GLM/PDM.

Gender: FEMALE

Ages: 18 Years - 65 Years

Updated: 2026-04-09

1 state

Granulomatous Mastitis
Mastitis Chronic
RECRUITING

NCT06665399

Observation Alone for Mild Non-Lactational Mastitis

The goal of this observational study is to investigate the disease progression rate and timing in patients with mild Non-Lactational Granulomatous Lobular / Periductal Mastitis (NL-GLM/PDM) during follow-up with observation alone strategy. The main questions it aims to answer are: What is the rate of disease progression in mild NL-GLM/PDM patients under observation, and what clinical and pathological factors are associated with this progression? Participants with diagnosis of mild NL-GLM/PDM will be monitored over a specified period, with data collected on their clinical outcomes and relevant factors influencing disease progression.

Gender: FEMALE

Ages: 18 Years - 65 Years

Updated: 2025-09-23

1 state

Granulomatous Mastitis
Mastitis Chronic
ACTIVE NOT RECRUITING

NCT05852171

Baricitinib in Idiopathic Granulomatous Mastitis

This study will explore the mechanism of targeted drug in treatment of idiopathic granulomatous mastitis, and clarify the clinical classification and corresponding markers.

Gender: FEMALE

Ages: 18 Years - 70 Years

Updated: 2025-05-14

1 state

Mastitis Chronic
Idiopathic Granulomatous Mastitis